Overall, these behavioral and biochemical data emphasize that ANXA1 restricts the initiation and maintenance of long-term pruritus via blocking spinal IL-17-mediated astrocyte activation and subsequently resolving neuroinflammation in both dermatitis and cholestasis. The gene discussed is ANXA1; the disease is dermatitis.